Atorvastatin: A Potential Treatment in COVID-19? Atorvastatin: A Potential Treatment in COVID-19?
Results of a randomized trial show no effect for severe COVID-19 patients in ICU, but there was a hint of benefit in the subgroup treated within 7 days of symptom onset in the INSPIRATION-S study.Medscape Medical News
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Cardiology News Source Type: news
More News: Atorvastatin Calcium | Cardiology | COVID-19 | Heart | Lipitor | Primary Care | Statin Therapy | Study | Zivast